Covered recipient · General Payments record
DIANE WALDER
General Payments · PY2018–2024
$2,827.27
- Reported across 170 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $493.03 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $311.15 | 20 |
| Galderma Laboratories, L.P. | $77.55 | 5 |
| REVANCE THERAPEUTICS, INC. | $52.05 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $28.12 | 1 |
| Smith & Nephew, Inc. | $24.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.02 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297681 | CMS |
| ABBVIE INC. | $27.95 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297683 | CMS |
| ABBVIE INC. | $22.38 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297685 | CMS |
| ABBVIE INC. | $4.97 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297687 | CMS |
| ABBVIE INC. | $23.30 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297689 | CMS |
| ABBVIE INC. | $27.89 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297691 | CMS |
| ABBVIE INC. | $27.84 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297693 | CMS |
| ABBVIE INC. | $5.91 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297695 | CMS |
| ABBVIE INC. | $32.29 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297697 | CMS |
| ABBVIE INC. | $4.29 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297699 | CMS |
| ABBVIE INC. | $14.66 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297701 | CMS |
| ABBVIE INC. | $7.00 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297703 | CMS |
| ABBVIE INC. | $28.95 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297705 | CMS |
| ABBVIE INC. | $5.86 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297707 | CMS |
| ABBVIE INC. | $24.87 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297709 | CMS |
| ABBVIE INC. | $7.03 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297711 | CMS |
| ABBVIE INC. | $26.98 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297713 | CMS |
| ABBVIE INC. | $3.99 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297715 | CMS |
| ABBVIE INC. | $2.41 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297717 | CMS |
| ABBVIE INC. | $6.56 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106297719 | CMS |
| Galderma Laboratories, L.P. | $16.18 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145334311 | CMS |
| Galderma Laboratories, L.P. | $13.08 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145334313 | CMS |
| Galderma Laboratories, L.P. | $16.43 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145334315 | CMS |
| Galderma Laboratories, L.P. | $13.18 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145334317 | CMS |
| Galderma Laboratories, L.P. | $18.68 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145334319 | CMS |
| REVANCE THERAPEUTICS, INC. | $52.05 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147931405 | CMS |
| Smith+Nephew, Inc. | $24.16 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149610691 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $28.12 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152144156 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.